NCT02393963View on ClinicalTrials.gov

Intra-articular Tranexamic Acid in the Reduction of Blood Transfusions in Primary Total Hip and Total Knee Arthroplasty

PHASE2CompletedINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

December 21, 2016

Conditions

Osteoarthritis

Interventions

DRUG

Tranexamic Acid

0.5g Tranexamic Acid in 0.9% Sodium Chloride (study group) will be injected into the joint after final closure through a temporary catheter that is brought out through the incision.

OTHER

Placebo

0.9% Sodium Chloride (placebo group) will be injected into the joint after final closure through a temporary catheter that is brought out through the incision.

Trial Locations (1)

R2K 3S8

Concordia Hospital, Winnipeg

All Listed Sponsors

lead

Orthopaedic Innovation Centre

OTHER

NCT02393963 - Intra-articular Tranexamic Acid in the Reduction of Blood Transfusions in Primary Total Hip and Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter